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Introduction
The inner mitochondrial membrane contains the four respira-
tory chain complexes that generate a proton gradient across the 
membrane that drives ATP synthesis by the F1Fo-ATPase. The 
electrons are eventually transferred to molecular oxygen by the 
terminal enzyme of the respiratory chain, the cytochrome oxi-
dase (complex IV). The respiratory chain complexes are multi-
subunit membrane protein complexes that contain cofactors for 
the transport of electrons (Saraste, 1999; Hosler et al., 2006). 
The majority of the subunits that form the respiratory chain 
complexes are encoded by nuclear genes and are imported into 
the organelle. In addition, complexes I, III, and IV contain core 
subunits that are encoded by mitochondrial genes and synthe-
sized on mitochondrial ribosomes (Fox, 1996; Herrmann and 
Neupert, 2003; van der Laan et al., 2006). These core subunits 
represent the starting points of protein complex assembly, and 
their expression is tightly regulated because misassembled sub-
units harbor the danger of generating reactive oxygen species 
with deleterious effects for the cell (Herrmann and Funes, 2005; 
Fontanesi  et  al.,  2006).  The  newly  synthesized  proteins  are 
probably co-translationally inserted into the inner mitochon-
drial membrane by the protein export machinery (Jia et al., 2003; 
Szyrach et al., 2003; Bonnefoy et al., 2009). To build a func-
tional protein complex from nuclear- and mitochondria-encoded 
subunits and to properly insert the cofactors, a large number of 
assembly factors are required. In the case of the cytochrome 
oxidase, >20 assembly factors in the yeast Saccharomyces cere-
visiae and human mediate the assembly process of 11 or 13 
structural subunits, respectively (Shoubridge, 2001; Carr and 
Winge, 2003; DiMauro and Schon, 2003; Fontanesi et al., 2006; 
R
egulation of eukaryotic cytochrome oxidase assem-
bly occurs at the level of Cox1 translation, its central 
mitochondria-encoded subunit. Translation of COX1 
messenger RNA is coupled to complex assembly in a neg-
ative feedback loop: the translational activator Mss51 is 
thought to be sequestered to assembly intermediates, ren-
dering it incompetent to promote translation. In this study, 
we identify Coa3 (cytochrome oxidase assembly factor 3; 
Yjl062w-A),  a  novel  regulator  of  mitochondrial  COX1 
translation and cytochrome oxidase assembly. We show 
that Coa3 and Cox14 form assembly intermediates with 
newly synthesized Cox1 and are required for Mss51 as-
sociation with these complexes. Mss51 exists in equilibrium 
between a latent, translational resting, and a committed, 
translation-effective, state that are represented as distinct 
complexes. Coa3 and Cox14 promote formation of the 
latent  state  and  thus  down-regulate  COX1  expression. 
Consequently, lack of Coa3 or Cox14 function traps Mss51 
in the committed state and promotes Cox1 synthesis. Our 
data indicate that Coa1 binding to sequestered Mss51 in 
complex with Cox14, Coa3, and Cox1 is essential for 
full inactivation.
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state to a translationally inactive state. Coa3 is in a complex 
with newly synthesized Cox1, Cox14, and Mss51. A lack of 
Coa3 or Cox14 leads to uncontrolled expression of COX1 due 
to a loss of the Mss51 negative feedback regulation. Concomi-
tantly, accumulated unassembled Cox1 is rapidly turned over in 
the mutants. Our findings allow novel insights into the mecha-
nism by which assembly of cytochrome oxidase is coupled to 
translational regulation of Cox1. Cox14 and Coa3 are essential 
for Mss51 recruitment to Cox1, a first step and prerequisite for 
its subsequent inactivation by Coa1. Thus, we suggest that gen-
eration of the latent state of Mss51 is not solely achieved by se-
questration but rather a multistep process of interactions in a 
defined order.
Results
Coa3 is a mitochondrial membrane protein 
in complex with Shy1
Defects in the function of assembly factors for respiratory chain 
complexes lead to loss of respiratory competence of cells and 
thus to severe human disorders. Interestingly, in the case of cyto-
chrome oxidase, assembly is functionally coupled to the regu-
lation of Cox1 expression, the central catalytic subunit of the 
complex. Defects in assembly of cytochrome oxidase can lead 
to down-regulation of Cox1 synthesis, preventing accumulation 
of  unassembled  Cox1. Although  two  molecules,  Mss51  and 
Cox14, which participate in the regulatory process, have been 
determined, little is known as to how the assembly state of Cox1 
is monitored at the molecular level. To identify proteins that are 
involved in early steps of cytochrome oxidase biogenesis and 
translational regulation, we isolated the assembly factor Shy1   
and associated proteins from purified mitochondria. Therefore, 
we used a functional protein A–tagged version of Shy1 (Mick 
et al., 2007). After solubilization of mitochondria, Shy1 and its 
associated proteins were purified by IgG chromatography. Shy1 
and bound proteins were released from the affinity matrix by 
tobacco etch virus protease treatment and analyzed by SDS-
PAGE followed by Western blotting and tandem mass spectrom-
etry (MS). In agreement with our previous analyses, subunits 
of cytochrome oxidase such as Cox1, Cox2, Cox5a, and Cox6 
were identified (Fig. 1 A), as well as subunits of the bc1 complex 
(not depicted; Mick et al., 2007). As expected, we also detected 
Coa1, Cox14, and Mss51 in the eluate (Mick et al., 2007), proteins 
which have been implicated in regulation of Cox1 expression. 
Moreover, we identified tryptic peptides by liquid chromatogra-
phy (LC)/tandem MS analysis that corresponded to a predicted 
novel protein with a molecular mass of 9.88 kD encoded by 
the open reading frame Yjl062w-A, later termed Coa3 (Fig. 1 C). 
The presence of Coa3 in the eluate was confirmed by Western 
blotting  using  antibodies  directed  against  the  C  terminus  of 
Coa3 (Fig. 1 A, lane 4). To confirm a mitochondrial localiza-
tion of the uncharacterized Coa3, we performed immunofluor-
escence analyses using Coa3 antibodies. The labeling pattern 
of the Coa3 antibody could be superimposed with mitochondria 
visualized by MitoTracker staining (Fig. 1 B). These analyses 
confirmed a mitochondrial localization of Coa3 in agreement 
with a proteomic study by Reinders et al. (2006). Coa3 is highly 
Fernández-Vizarra et al., 2009). Defects in the function of as-
sembly factors compromise the activity of the respiratory chain 
and affect the metabolism of the cell. Thus, such defects lead to 
respiratory deficiency in yeast and cause severe neuromuscular 
disorders in human, the so-called mitochondrial encephalo-
myopathies (DiMauro and Schon, 2003). In fact, defects in trans-
lation of mitochondrial mRNAs are among the most common 
causes of mitochondrial diseases (Taylor and Turnbull, 2005; 
Weraarpachai et al., 2009). However, the molecular mechanisms 
regulating mitochondrial gene expression are ill defined.
SURF1, the human homologue of the yeast Shy1 protein, 
is a cytochrome oxidase assembly factor, which is important for 
the biogenesis of the mitochondria-encoded Cox1 protein, the 
core subunit of the complex. Deletion of the SHY1 gene in yeast 
leads to severe reduction of cytochrome oxidase complexes and 
growth defects on nonfermentable medium (Mashkevich et al., 
1997; Nijtmans et al., 2001). In human, mutations in SURF1 are 
among the major causes for Leigh syndrome (Online Mende-
lian Inheritance in Man ID 256000), a subacute necrotizing 
encephalomyopathy which is commonly associated with sys-
temic cytochrome oxidase deficiency (Tiranti et al., 1998; Zhu 
et al., 1998). The yeast Shy1 protein was found in association 
with early assembly intermediates of Cox1, and similarly, Leigh 
syndrome patients often accumulate aberrant forms of the cyto-
chrome oxidase that are likely to represent intermediates of the 
biogenesis process (Coenen et al., 1999; Williams et al., 2004). 
Although the molecular function of Shy1/SURF1 is still enigmatic, 
recent analyses suggest a direct or indirect role in incorporation 
of cofactors such as copper and heme into Cox1 (Smith et al., 
2005; Pierrel et al., 2007; Bundschuh et al., 2009). Moreover, 
Shy1 interactions included subunits involved in the regulation 
of COX1 expression (Mick et al., 2007; Pierrel et al., 2007).
Translation of COX1 mRNA is tightly linked to the assembly 
process of the Cox1 protein. Two translational activator pro-
teins, Pet309 and Mss51, specifically recognize the COX1 mRNA 
and are essential for its translation (Decoster et al., 1990; Manthey 
and McEwen, 1995; Perez-Martinez et al., 2003; Zambrano et al., 
2007). Moreover, Mss51 plays an undefined role in the assem-
bly process (Barrientos et al., 2004; Perez-Martinez et al., 
2009). Mss51 is associated with the inner mitochondrial mem-
brane where it forms complexes with newly synthesized Cox1, 
Cox14, Coa1 (cytochrome oxidase assembly factor 1), and Shy1 
(Mick et al., 2007; Pierrel et al., 2007; Khalimonchuk et al., 
2010). In this complex, Mss51 is maintained in an inactive state 
and is unable to promote Cox1 expression. In the course of the 
Cox1 assembly process, Cox1 associates with additional sub-
units of the complex, leading to a release of Mss51 that is re-
activated and can initiate COX1 mRNA translation. Thus, expression 
of Cox1 is intimately coupled to its assembly process (Perez-
Martinez et al., 2003; Barrientos et al., 2004; Herrmann and   
Funes, 2005; Khalimonchuk and Rödel, 2005; Fontanesi et al., 
2006). However, it is unclear how the assembly state of Cox1 in 
the membrane is monitored and what molecular roles Coa1, 
Cox14, and Shy1 play in regulating Mss51 activity.
In this study, we identify Coa3 as a novel regulator of Cox1 
expression in mitochondria. Together with Cox14, Coa3 is required 
to alter the equilibrium of Mss51 from the translation-promoting 143 Regulation of mitochondrial COX1 translation • Mick et al.
when mitochondria were treated with increasing amounts of pro-
tease. When the mitochondrial outer membrane was disrupted 
osmotically, protein domains, which are exposed to the inter-
membrane space (IMS), become accessible to protease treat-
ment. Under these conditions, the C termini of Coa3 and Cox14 
were degraded similarly to the IMS domain of Tim23 (Fig. 1 E, 
lane 8 vs. lane 9), indicating that both proteins expose their 
C termini into the IMS. No stable fragments of Coa3 or Cox14 
were detected using antibodies directed against the C termini of 
both proteins (Fig. S1 B). As a control, the matrix protein Tim44 
remained resistant to protease treatment after swelling and be-
came only accessible when the inner membrane was disrupted 
with Triton X-100 (Fig. 1 E, lanes 6–9). In summary, Coa3 
and Cox14 are integral membrane proteins that expose their 
C termini into the IMS. Taking the prediction of a single trans-
membrane segment into consideration, it appears likely that the 
N termini of both proteins are exposed to the matrix.
Coa3 is required for cytochrome  
oxidase biogenesis
To assess the function of Coa3 in mitochondria, we deleted the 
COA3 open reading frame. coa3 mutant cells displayed a se-
vere growth defect on nonfermentable carbon sources at all 
conserved among yeast species. An in silico analysis of Coa3 
did not indicate a significant probability for the presence of a 
cleavable N-terminal presequence. Moreover, a single segment   
with the potential to represent a transmembrane helix was iden-
tified, suggesting that Coa3 could represent a mitochondrial mem-
brane protein (Fig. 1 C and Fig. S1 A).
To assess whether Coa3 is a mitochondrial membrane pro-
tein, we performed carbonate extraction analyses of isolated 
mitochondria. The soluble Aconitase (Aco1) was released from 
mitochondria by sonication, and the peripheral mitochondrial 
membrane protein Tim44 was only released efficiently by carbon-
ate treatment (Fig. 1 D). In contrast, Coa3 was carbonate re-
sistant and remained in the carbonate pellet similar to the integral 
membrane protein Tom70 (Fig. 1 D, lane 6). Thus, Coa3 behaves 
as an integral membrane protein. Interestingly, in contrast to pre-
vious analyses (Barrientos et al., 2004), when we assessed the 
fractionation pattern of Cox14 using antibodies directed against 
its C terminus, we found that Cox14 was similarly resistant to 
carbonate extraction and thus behaved as an integral membrane 
protein (Fig. 1 D, lane 6). In agreement with this, a single seg-
ment with the potential to span a membrane was predicted in 
Cox14 (Fig. S1 A). To address membrane topology of Coa3, we 
performed protease protection experiments. Coa3 remained stable 
Figure 1.  Coa3 is a mitochondrial inner mem-
brane protein facing the IMS. (A) Isolated wild-
type  (WT)  and  Shy1
ProtA  mitochondria  were 
solubilized and subjected to IgG chromatog-
raphy. After tobacco etch virus (TEV) protease 
cleavage,  eluates  were  analyzed  by  SDS-
PAGE, Western blotting, or peptide LC/tandem 
MS. The asterisk marks ADP/ATP carrier, an 
impurity of purification. Cytochrome bc1 com-
plex components identified are not depicted 
(Mick et al., 2007). (B) Immunofluorescence 
analysis  using  MitoTracker  red  and  Coa3- 
specific antibodies. Bars, 5 µm. (C) Alignment 
of Coa3 homologues (ClustalW 2.0.11). Black 
boxes indicate identical residues in at least five 
species; gray boxes indicate similar amino   
acids. Black underlining indicates the predicted 
transmembrane  segment.  Sc,  S.  cerevisiae; 
Nc, Neurospora crassa; Yl, Yarrowia lipolytica; 
Pp, Pichia pastoris; Ag, Ashbya gossypii; and 
Kl, Kluyveromyces lactis. (D and E) Membrane 
association  and  submitochondrial  localiza-
tion of Coa3 as described in Materials and 
methods. T indicates the total; S and P indicate 
the supernatant and pellet, respectively, after 
ultracentrifugation. TX-100, Triton X-100; PK, 
proteinase K.JCB • VOLUME 191 • NUMBER 1 • 2010   144
mild detergent digitonin. bc1 complex forms a dimer (III2) that 
can associate with a single (III2IV) or two cytochrome oxidase 
(III2IV2) monomers. The bc1 complex was exclusively present 
in its dimeric form in coa3 and cox14 mitochondria and 
we were unable to detect cytochrome oxidase with antibodies 
against the nuclear-encoded subunits Cox4 and Cox13 (Fig. 2 C). 
Thus, we conclude that active cytochrome oxidase complex was 
absent from coa3 and cox14 mitochondria. To determine the 
basis for the lack of cytochrome oxidase, we analyzed the 
steady-state protein levels of selected mitochondrial proteins. 
In coa3 mitochondria, the mitochondria-encoded subunits of 
cytochrome oxidase, Cox1 and Cox2, were not detected, and 
the nuclear-encoded subunit Cox13 was dramatically reduced. 
In contrast, Qcr6 and Cyt1 (bc1 complex) and the nuclear-encoded 
Cox4 (cytochrome oxidase) were present in similar amounts 
compared with the wild-type control. Moreover, we assessed 
the levels of assembly factors for cytochrome oxidase (Fig. 2 D). 
Although Shy1 levels were not affected, the levels of Coa1 were 
tested temperatures but displayed wild-type–like growth on 
fermentable medium (Fig. 2 A), in agreement with recent data 
from a genome-wide screen on respiratory-deficient mutants 
(Merz and Westermann, 2009). This growth defect was indistin-
guishable from the behavior of cox14 mutant cells, which is 
indicative of a defect in respiration. To determine the cause of 
the growth phenotype, we measured the activity of respiratory 
chain complexes and malate dehydrogenase as a control in iso-
lated mitochondria. The activities of the bc1 complex (complex III) 
and malate dehydrogenase were similar between wild type, 
cox14, and coa3 mitochondria. In contrast, cytochrome oxi-
dase activity was drastically reduced in cox14 and coa3 mito-
chondria (Fig. 2 B).
To address the reason for the lack of cytochrome oxidase 
activity in coa3 mitochondria, we analyzed respiratory chain 
complexes by blue native PAGE (BN-PAGE). In yeast, the re-
spiratory chain complexes associate as supercomplexes, which 
can be separated by BN-PAGE upon solubilization with the 
Figure 2.  coa3 yeast cells are respiratory deficient and lack cytochrome oxidase. (A) Wild-type (WT), coa3, and cox14 yeast cells were spotted in 
serial 10-fold dilutions on fermentable (glucose) and nonfermentable (glycerol) media. (B) Enzyme assays of isolated mitochondria. Means of four inde-
pendent experiments (SEM; n = 4). (C) Solubilized mitochondria were separated by BN-PAGE and analyzed by Western blotting. (D) Mitochondria (Mito) 
were separated by SDS-PAGE and analyzed by Western blotting.145 Regulation of mitochondrial COX1 translation • Mick et al.
The 250–400-kD complexes resembled in size cytochrome oxi-
dase assembly intermediates formed by Shy1 and Cox1 (Fig. 3 B, 
lanes 1 and 4; Mick et al., 2007). These complexes were absent 
in coa3 and cox14 mitochondria (Fig. 3 B, lanes 2, 3, 5, and 6). 
This could be explained by the fact that Coa3 and Cox14 are 
themselves part of the complexes or the lack of Cox1 in mito-
chondria (Fig. 2 D). To distinguish between these possibilities, 
we imported Shy1, Cox14, and, as a control, the early assem-
bling subunit Cox5a (Nijtmans et al., 1998; Mick et al., 2007; 
Fontanesi et al., 2008; Barrientos et al., 2009) into Coa3
HA 
mitochondria. After solubilization, anti-HA or control antibodies 
were added to all samples, and analyses of complexes were 
performed by BN-PAGE. The anti-HA antibodies directed 
against Coa3 specifically shifted the 250–400-kD Shy1-, Cox14-, 
and Cox5a-containing complexes in size. In contrast, super-
complexes, which only contain low amounts of Coa3 (see Fig. S2 A),   
remained largely unaffected (Fig. 3 C). We will refer to these 
250–400-kD complexes as COA complexes for cytochrome   
slightly increased in coa3 mutant mitochondria. In contrast, 
a lack of Coa3 had no effect on levels of Cox14 and vice versa. 
Interestingly, the steady-state protein levels of cox14 mito-
chondria  were  virtually  indistinguishable  from  coa3  mito-
chondria (Fig. 2 D, lanes 4–6 vs. lanes 7–9). Thus, a lack of 
selected subunits of cytochrome oxidase appears to lead to loss 
of respiratory competence of cox14 and coa3 cells.
Coa3 associates with assembly factors  
and regulators of COX1 expression
Coa3  was  identified  by  copurification  with  Shy1-containing 
complexes. Thus, we analyzed complex formation of Coa3 by 
BN-PAGE using a functional C-terminally tagged version of 
Coa3. Coa3 was mainly detected in complexes of 250–400 kD 
(Fig. 3 A, lane 2). Moreover, upon longer exposure, a small 
fraction of Coa3 co-migrated with respiratory chain super-
complexes (Fig. S2 A). This was further supported by coisolation 
of Coa3 with respiratory chain supercomplexes (Fig. S2 B).   
Figure 3.  Coa3 associates with newly synthesized Cox1. (A) Wild-type (WT) and Coa3
HA mitochondria were solubilized and analyzed by BN-PAGE and 
Western blotting. (B) Wild-type and mutant mitochondria were analyzed as in A. (C) Radiolabeled Shy1, Cox5a, and Cox14 were imported into isolated 
mitochondria containing Coa3
HA. Mitochondria were solubilized and incubated with Flag (control) or HA antibodies before separation by BN-PAGE and 
digital autoradiography. (D) IgG chromatography of isolated mitochondria from wild type, Mss51
TAP, or Cox14
TAP. Samples were analyzed by SDS-PAGE 
and Western blotting. The asterisk indicates a cross-reactive signal detected by Mss51 antiserum. (E) In organello translation of isolated Coa3
HA mito-
chondria was performed, and the sample was split and subjected to coimmunoprecipitations with anti-Flag (control) or anti-HA antibodies. Samples were 
analyzed by SDS-PAGE and digital autoradiography. (D and E) The amounts of protein loaded in the total samples correspond to 2% of the eluate.JCB • VOLUME 191 • NUMBER 1 • 2010   146
from both mitochondria, only minute amounts of Cox14, Coa1, 
and Mss51 were coimmunoprecipitated in cox1
 mitochondria, 
indicating that all interactions with Coa3 largely depend on the 
presence of Cox1. In contrast, when Cox1 accumulated in an 
unassembled or partially assembled state such as in the case 
of cox2
 mitochondria, Cox14, Coa1, Mss51, Shy1, and Cox1 
were associated with Coa3 (Fig. 4 B). To assess whether pro-
teins associate with Coa3 in distinct or similar complexes, we 
performed immunodepletion analyses. Therefore, we incubated 
mitochondrial extracts from cox2
 mitochondria with Coa3 or 
preimmune serum coupled to protein A–Sepharose and sepa-
rated complexes that remained in the unbound fraction on 
BN-PAGE. Although partially assembled supercomplexes that 
contain Cox1 (Mick et al., 2007) were not depleted by the anti-
body treatment (Fig. 4 C, lanes 1 and 2), the 250–400-kD COA 
complexes were fully depleted from the extract, and antibodies 
against Cox1, Coa1, Coa3, and Cox14 did not detect residual 
amounts of complexes in this range (Fig. 4 C). (Unfortunately, 
antibodies against Mss51 were not of sufficient quality to detect 
Mss51 complexes on BN-PAGE.) Accordingly, Coa3, Cox14, 
Coa1, and Cox1 are constituents of the COA complexes.
Because  Coa3  was  identified  through  its  association 
with Shy1, we asked whether Shy1 was required for COA com-
plex formation. Coa3 antibodies efficiently precipitated Cox14, 
Coa1, Cox1, and Mss51 from shy1 mitochondria (Fig. 4 D, 
lanes 4 and 5). Note that Cox1 levels are dramatically decreased 
in shy1 mitochondria (Nijtmans et al., 2001; Barrientos et al., 
2002; Mick et al., 2007), whereas the coprecipitation efficiency 
was only slightly reduced compared with the wild-type control. 
Thus, Shy1 is obviously not required for complex formation be-
tween Coa3, Cox14, Coa1, Cox1, and Mss51. Previous work 
had linked Coa1 to Cox1 translational regulation (Mick et al., 
2007; Pierrel et al., 2007). This observation and the presence of 
Coa1 in the COA complexes led us to assess its involvement in 
complex formation. When Coa3 was immunoprecipitated from 
coa1 mitochondria, the coprecipitation efficiency was slightly 
decreased compared with wild-type and shy1 mitochondria; 
however, Cox14, Cox1, and Mss51 were still efficiently copre-
cipitated with Coa3, whereas Shy1 was not recovered (Fig. 4 D, 
lanes 7 and 8). Thus, binding of Coa3 to Cox14, Mss51, and to 
unassembled Cox1 itself is independent of Coa1 and Shy1 (see 
Coa3 and Cox14 are required for Mss51 association with newly 
synthesized Cox1). However, the presence of Coa1 is a pre-
requisite for Shy1 recruitment into the complex.
Coa3 and Cox14 negatively regulate  
COX1 translation
The association of Coa3 with Mss51 and Cox14 pointed toward 
a possible function in the COX1 translational regulation. Cox14 
is considered to bind to Cox1 and to sequester Mss51 in an in-
active state and thus to prevent new rounds of Cox1 translation 
(Barrientos et al., 2004). Therefore, we analyzed Cox1 synthesis 
in wild-type and mutant cells in a pulse-chase analysis. After a   
5-min pulse with [
35S]methionine, the synthesis of Cox1 was dra-
matically increased in the absence of Cox14 or Coa3 (Fig. 5 A, 
lanes 3 and 4). In agreement with previous in organello analy-
ses, a lack of Coa1 resulted only in a slight increase of Cox1 
oxidase  assembly  intermediates.  We  conclude  that  Cox14, 
Shy1, and Cox5a together with Coa3 are constituents of the 
COA complexes in agreement with the association seen in the 
purification of Shy1
ProtA.
Cox14 has been implicated in the feedback regulation of 
Cox1 translation through an association with the translational 
activator Mss51 (Perez-Martinez et al., 2003; Barrientos et al., 
2004). Thus, we analyzed whether Coa3 was also in complex 
with Mss51 by purification of Mss51 and Cox14 complexes 
from mitochondria. Besides the known associated components, 
such as Shy1, Cox1, Cox14, and Coa1, Coa3 was efficiently co-
purified with Mss51 (Fig. 3 D, lanes 4 and 10). Similarly, puri-
fication of Cox14 led to coisolation of Shy1, Cox1, Mss51, 
Coa1, and Coa3 (Fig. 3 D). Because a fraction of Cox14 associ-
ates with respiratory chain supercomplexes (Fig. 3 C; Mick et al., 
2007), additional subunits of cytochrome oxidase and bc1 com-
plex are coisolated with Cox14 (Fig. 3 D, lane 12; and Fig. S2 C). 
Accordingly, Coa3 is in complex with Cox14 and Mss51. 
Therefore, we assessed a role of Coa3 in Cox1 biogenesis di-
rectly by analyzing whether Coa3 was associated with newly 
synthesized Cox1. We pulse labeled mitochondrial translation 
products in mitochondria that contained Coa3
HA and performed 
immunoprecipitation experiments using antibodies against HA 
or control antibodies. Although control antibodies did not pre-
cipitate significant amounts of Cox1, newly synthesized Cox1 
was specifically precipitated with Coa3
HA (Fig. 3 E, lane 5).   
In summary, Coa3 interacts with newly synthesized Cox1, simi-
lar to Mss51 and Cox14 (Perez-Martinez et al., 2003; Barrientos 
et al., 2004). Moreover, Coa3 associates with the assembly factor 
Cox14 in COA complexes of 250–400 kD and is in complex with 
the translational regulator Mss51.
Coa3 association with the translational 
regulator machinery depends on Cox1
To define protein associations of Coa3 and their dynamics in 
more detail, we established conditions to immunoprecipitate the 
untagged Coa3 from mitochondrial membranes. An antibody 
directed against the C terminus of Coa3 efficiently immuno-
precipitated the protein and was able to deplete it from digitonin-
solubilized mitochondria (Fig. 4 A, lane 1 vs. lane 3). The Coa3 
antibodies specifically coimmunoprecipitated significant amounts 
of Cox14, Coa1, Cox1, and Shy1. Similarly, Mss51 was effi-
ciently precipitated from the mitochondrial extract. As controls, 
we performed precipitations with preimmune serum and checked 
precipitates for the presence of unrelated mitochondrial proteins. 
The preimmune serum did not precipitate any of the components. 
Control proteins such as Atp5, Porin (Por1), Tom70, Tim23, 
and Aco1 were not precipitated with Coa3 antibodies (Fig. 4 A, 
lane 4 vs. lane 5).
Given the tight connection of the interacting factors to 
Cox1 assembly, we asked which of the protein interactions were 
dependent on the presence of Cox1. Thus, we performed immuno-
precipitations from mitochondria lacking Cox1 (cox1
) and as 
a control of mitochondria lacking Cox2 (cox2
). In cox2 mutant 
mitochondria, mature cytochrome oxidase is not formed, but 
assembly intermediates of Cox1 accumulate (Horan et al., 2005; 
Mick et al., 2007). Although Coa3 was efficiently precipitated 147 Regulation of mitochondrial COX1 translation • Mick et al.
phenotype  was  observed  (unpublished  data),  indicating  that 
both proteins fulfill distinct functions.
The observation that Cox1 synthesis was drastically in-
creased in the absence of Coa3 or Cox14 was unexpected be-
cause the steady-state levels of Cox1 were severely affected 
(Fig. 2 D). We speculated that the newly synthesized Cox1 was 
especially unstable in coa3 and cox14 mutants. To address 
this hypothesis, we performed pulse labeling of mitochondrial 
translation products in whole cells and monitored the amounts 
of Cox1 protein in an extended chase. Newly synthesized Cox1 
synthesis (Fig. 5 A, lane 5; Mick et al., 2007). However, Cox1   
translation was reduced when Shy1 or structural subunits of 
cytochrome oxidase, such as Cox4, were absent (Fig. 5 A, 
lanes 2 and 6; Barrientos et al., 2004). This reduction is probably 
caused by the occurring sequestration of Mss51 by Coa3 and 
Cox14. Thus, we conclude that both Cox14 and Coa3 nega-
tively regulate Cox1 synthesis in mitochondria. Therefore, we 
tested whether overexpression of either Cox14 in coa3 mutant 
cells or of Coa3 in cox14 mutant cells suppressed the growth 
phenotype of the mutants. However, no effect on the growth 
Figure 4.  Formation of COA complexes strictly depends on Cox1; sequestration of Mss51 is independent of Cox2, Shy1, and Coa1. (A) Coimmunoprecipi-
tations of Coa3 from digitonin-solubilized mitochondria. After solubilization, samples were incubated with Coa3-specific or preimmune (control) antisera. 
Bound material was eluted and analyzed by SDS-PAGE and Western blotting. The amounts of protein loaded in the total and unbound samples correspond 
to 6% of the eluate. (B) Coimmunoprecipitation experiments as in A were performed in cox1
 and cox2
 mitochondria. (C) Isolated cox2
 mitochondria 
were solubilized in digitonin and subjected to immunoprecipitation with Coa3 or preimmune (control) antisera. Lysates were depleted from antibody-bound 
complexes with protein A–Sepharose, and unbound material was separated by BN-PAGE, followed by Western blot analysis. (D) Coimmunoprecipita-
tion experiments from wild-type (WT), shy1, and coa1 mitochondria were performed as in A except that anti-Atp5 antiserum was used as a control.   
(A and D) Asterisks indicate a cross-reactive signal detected by Mss51 antiserum.JCB • VOLUME 191 • NUMBER 1 • 2010   148
cox14 or coa3 displayed reduced Cox1 stability similar to 
single coa3 or cox14 cells (Fig. S3 B).
Coa3 and Cox14 are required for Mss51 
association with newly synthesized Cox1
Mss51 is required for translation of COX1 mRNA. Recruit-
ment of Mss51 to unassembled Cox1 in complex with Cox14 is 
thought to be essential to inactivate Mss51 (Perez-Martinez et al., 
2003; Barrientos et al., 2004). Thus, we assessed Mss51 binding 
to newly synthesized Cox1 in wild-type and mutant mitochondria 
by coimmunoprecipitation. Although newly synthesized Cox1 
was efficiently bound by Mss51 in wild-type mitochondria, 
Cox1 binding was severely reduced and close to background   
levels in coa3 and cox14 mitochondria (Fig. 6 A). In contrast, 
in coa1 mitochondria, a mild but obvious reduction of Cox1 
remained relatively stable over a time course of 45 min in wild-
type and shy1 cells (Fig. 5, C [lanes 1–4 and 17–20] and D; 
and Fig. S3 A). The lack of nuclear-encoded structural subunits 
such as Cox6 or the assembly factor Coa1 led to a slight de-
crease in Cox1 stability (Fig. 5, C [lanes 13–16 and 21–24] and D). 
In contrast, Cox1 was rapidly turned over in both coa3 and 
cox14 mitochondria (Fig. 5 C, lanes 5–12). Thus, we conclude 
that association of Coa3 and Cox14 to newly synthesized Cox1 
directly or indirectly protects it from turnover by the quality 
control system (Arlt et al., 1996; Guzélin et al., 1996). In contrast 
to Coa3 and Cox14, Coa1 seems to play a later role because a lack 
of Coa1 affects Cox1 translation or stability only mildly. To support 
this conclusion, we generated coa1cox14, coa1coa3, and 
cox14coa3 double mutant strains and assessed Cox1 stabil-
ity in these cells. As expected, double mutants of coa1 with 
Figure 5.  coa3 and cox14 yeast cells display increased COX1 expression and reduced stability of Cox1. (A) In vivo labeling of mitochondrial trans-
lation products was performed according to Materials and methods. After 5-min pulse, cells were lysed and subjected to TCA precipitation, and labeled pro-
teins were analyzed by SDS-PAGE and digital autoradiography. (B) Three independent experiments as in A were quantified using ImageQuant TL software 
(GE Healthcare). Values represent the mean ratios of Cox1/Var1, relative to wild type (WT; 100%). Error bars indicate SEM (n = 3). (C) In vivo labeling of 
mitochondrial translation products was performed as in A. After 5-min pulse, translations were stopped by the addition of excess unlabeled methionine and 
chloramphenicol. Samples were taken after 5-, 15-, and 45-min chase and analyzed as in A. (D) Four independent experiments as in C were quantified 
using ImageQuant TL software, and Cox1 signals were plotted against chase times. Values represent mean ratios of Cox1/Cob, relative to 0-min chase (100%). 
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However, the apparent molecular weights of the complexes 
observed in this study are different in size. Thus, we investigated 
whether Coa3 and other assembly factors were constituents of 
Mss51 complexes and asked how they are linked to mitochon-
drial translation. Therefore, mitochondria were isolated from 
cells treated with the translational inhibitors chloramphenicol or 
cycloheximide. Chloramphenicol inhibits mitochondrial transla-
tion, whereas cycloheximide treatment stops supply of nuclear-
encoded cytochrome oxidase subunits and leads to accumulation 
binding to Mss51 was observed. Thus, recruitment of Mss51 to 
newly synthesized Cox1 depends on the presence of Coa3 as 
well as Cox14 but not on Coa1.
To assess Mss51 complexes in mitochondria at steady-
state, we chromosomally integrated a HA-tagged version replac-
ing the wild-type Mss51. Mss51
HA was detected in three distinct 
complexes in BN-PAGE analyses of digitonin-solubilized mito-
chondria (Fig. 6 B). This pattern resembles previous observa-
tions for an Mss51
MYC construct (Khalimonchuk et al., 2010). 
Figure 6.  Mss51 complexes are dynamic in nature. (A) In organello labeling of mitochondrial translation products was performed in the indicated strains, 
expressing Mss51
HA. Coimmunoprecipitation experiments were analyzed as in Fig. 3 E. Autoradiograph signals were quantified using ImageQuant TL 
software. The ratios of signals for Cox1, Cox2, and Cob between eluate and total were calculated and normalized to the Cox1 eluate/total ratio in wild 
type (WT; 100%). Means of three independent experiments (SEM; n = 3) are shown. (B) Mss51
HA and wild-type mitochondria were solubilized and ana-
lyzed by BN-PAGE and Western blotting using anti-HA antibodies. (C) Mitochondria isolated from Mss51
HA yeast cells treated with chloramphenicol (CAP) 
or cycloheximide (CHX) were analyzed as in B. Brackets indicate the molecular mass range of the Mss51 complexes. Lanes 1–4 in the bottom panels 
are cropped from the top panels and displayed with increased contrast for Cox1. (D) Solubilized mitochondria from pretreated cells were subjected to 
coimmunoprecipitation with anti-HA and control antibodies and analyzed by SDS-PAGE and Western blotting.JCB • VOLUME 191 • NUMBER 1 • 2010   150
and larger complexes with Cox1, Coa1, Cox14, and Coa3 as the   
inactive forms. The analysis of untreated mitochondria (Fig. 6 B) 
shows that at steady-state, all forms of Mss51 are present, sug-
gesting that they are in a dynamic equilibrium. Treatment with 
chloramphenicol  or  cycloheximide  shifts  the  equilibrium  to 
provide a view of the two extreme states of Mss51.
Lack of Coa3 or Cox14 shifts  
the equilibrium of Mss51 complexes  
to the translation-committed state
To provide direct evidence that at steady-state Cox14, Coa1, 
and Coa3 are together in the 250- and 300-kD complexes with 
Mss51, we performed antibody depletion BN-PAGE analyses. 
Antibodies directed against Coa3, Cox14, and Coa1 completely 
depleted the 250- and 300-kD complexes from solubilized mito-
chondria (Fig. 7 A, lanes 2–4). In contrast, the MSS51
TE complex 
was not affected by the treatment. As a control, we used anti-
bodies directed against Atp5 that did not affect Mss51 complexes 
(Fig. 7 A, lane 1). Thus, Cox14, Coa3, and Coa1 are specific con-
stituents of the Mss51 complexes representing its latent state.
What is the role of Coa3 or Cox14 in Mss51 regulation? 
To address this question, we analyzed Mss51 complexes in mutant 
mitochondria by BN-PAGE. A lack of Coa3 or Cox14 shifted 
the equilibrium of Mss51 complexes toward the MSS51
TE com-
plex. The larger 250- and 300-kD COA complexes were absent 
of unassembled Cox1 (Fig. 6 C, lanes 3 and 4). In the latter case, 
Mss51 was found exclusively in 250- and 300-kD complexes, 
and, according to the sequestration model, Mss51 should be in-
activated through association with unassembled Cox1 into COA 
complexes. In support of this, we detected Cox1, Coa1, Coa3, 
and Cox14 in complexes that co-migrated with the 250- and 
300-kD COA complexes (Fig. 6 C), suggesting that in complex 
with these four proteins, Mss51 is in the latent, translational 
resting state. In contrast, chloramphenicol treatment shifted 
the distribution of Mss51 to a 180-kD complex, whereas only 
minute amounts of the 250-kD complex were detected. In this 
study, recruitment of unassembled Cox1 to imported subunits 
releases Mss51 into a smaller translation-effective complex of 
180  kD  (MSS51
TE;  translation  effective),  with  Mss51  being 
the only constituent identified so far (Fig. 6 C). To confirm 
physical associations, we performed coimmunoprecipitation of   
Mss51
HA. In agreement with the results of the BN-PAGE analyses,   
Mss51 was associated with Coa3, Cox14, Cox1, and Coa1 only 
when assembly intermediates accumulated (Fig. 6 D, lane 4), 
whereas the interactions were mostly lost when mitochon-
drial translation was blocked (Fig. 6 D, lane 6). In summary, 
by changing conditions for the function of Mss51 between its 
committed, translation-stimulating situation, and the latent, 
translation-inactive state, we were able to assign the low mo-
lecular weight complex of Mss51 as the translation-promoting 
Figure 7.  Lack of Coa1 stalls Mss51 in a 250-kD complex. (A) Mss51
HA mitochondria were solubilized, and samples were split and incubated with in-
dicated antibodies. Antibodies with bound material were precipitated with protein A–Sepharose, and unbound material was analyzed by BN-PAGE and 
Western blotting using anti-HA antibodies. Respiratory chain supercomplexes and carrier translocase (TIM22) were detected with anti-Cox1 or anti-Tim54 
antibodies, respectively. (B) Mitochondria from the indicated mutants expressing Mss51
HA were analyzed as in A. (C) Antibody depletion experiments were 
performed in coa1 mitochondria as in A. For comparison, untreated wild-type (WT) mitochondria were analyzed in lane 1.151 Regulation of mitochondrial COX1 translation • Mick et al.
assembly factors could play a role in repair processes of mature 
complexes or alternatively associate with not fully assembled 
intermediates that already bind to complex III.
Newly synthesized Cox1 is associated with Cox14 and 
Coa3, even in the absence of Coa1 or Shy1. Moreover, Mss51 
binding to newly synthesized Cox1 requires Coa3 and Cox14, 
and at the same time Mss51 binding to Cox14 and Coa3 depends 
on Cox1 but not on Coa1 or Shy1. Thus, the 12 times membrane-
spanning Cox1 protein is apparently recognized by two trans-
membrane proteins: Cox14 and Coa3. These observations 
extend a recent study, which showed that the Cox14 interaction 
with Mss51 requires Cox1 (Perez-Martinez et al., 2009). Loss 
of Cox14 or Coa3 function leads to similar defects in the bio-
genesis of Cox1: Cox1 expression is significantly increased, 
and the newly synthesized Cox1 is rapidly turned over. How can 
these opposing effects be explained? Mss51 interacts with the 
5 untranslated region of the COX1 mRNA and promotes transla-
tion (Decoster et al., 1990; Perez-Martinez et al., 2003; Barrientos 
et al., 2004). Cox14 was believed to represent the sole link be-
tween Cox1 and Mss51 and to mediate inactivation by physical 
sequestration of Mss51 (Perez-Martinez et al., 2003; Barrientos 
et al., 2004). Loss of Cox14 would release Mss51 in its active 
state to stimulate Cox1 expression. In this study, we show that 
the mechanism of the regulatory circuit is more complex than 
anticipated and possibly not just a topological phenomenon. 
First, Cox14 and Coa3 are not membrane-associated proteins, 
fully exposed to the matrix, which only serve as bridging pro-
teins to sequester Mss51; they are integral membrane proteins 
with small domains exposed to the IMS as well as the matrix. 
Second, both membrane proteins, Cox14 and Coa3, are required 
to bind to the unassembled Cox1 and to communicate back for 
translational regulation. Despite the fact that coa3 and cox14 
mutant mitochondria display virtually indistinguishable pheno-
types, we did not observe crosswise suppression of the mutant 
growth phenotype upon overexpression of Coa3 or Cox14, indi-
cating that they fulfill independent functions. In contrast to what 
is found in cox14 and coa3, loss of Coa1 causes only a slight 
increase in translation and destabilization of Cox1 (Fig. 5; Mick 
et al., 2007). The analysis of Cox1 stability in double mutants sup-
ports the conclusion that Coa1 acts downstream of Cox14 and 
Coa3. In agreement with this observation, a 250-kD complex 
consisting of Mss51, Coa3, Cox14, and Cox1 is formed in the ab-
sence of Coa1. In contrast, recruitment of Shy1 depends on the 
presence of Coa1 in the complex.
How is the regulation of translation linked to complex 
assembly? Assembly of Cox1 requires factors that chaperone the 
compilation of nuclear-encoded subunits with Cox1, insertion of 
cofactors, and addition of mitochondrial-encoded Cox2 and Cox3 
(Herrmann and Funes, 2005; Fontanesi et al., 2006). The process 
appears to occur through distinct assembly steps, and defects 
in this process can lead to the accumulation of assembly inter-
mediates (Nijtmans et al., 2001; Williams et al., 2004; Stiburek 
et al., 2005; Mick et al., 2007).
Mss51 is present in different complexes that we assign 
to its functional state. Under conditions that inactivate Mss51 
through accumulation of Cox1 assembly intermediates (loss of 
supply of nuclear-encoded subunits) Mss51 is present in 250- and 
in these mitochondria at steady-state (Fig. 7 B, lanes 3 and 5). 
Using anti-HA antibodies directed against Mss51
HA for depletion 
analyses, we demonstrated the authenticity of the Mss51 com-
plexes. The altered complex pattern of Mss51 in cox14 and 
coa3 mitochondria is in full agreement with the increased 
translation phenotype observed in the mutants (Fig. 5 B). Inter-
estingly, analysis of coa1 mitochondria revealed the presence 
of Mss51 primarily in a 250-kD complex, which accumulates 
compared with the wild-type situation (Fig. 7 B, lane 7). In these 
mitochondria, MSS51
TE was not detected. It appears likely that, 
despite a lack of an obvious size difference on BN-PAGE, the 
observed 250-kD complex in coa1 is similar to the 250-kD 
complex  of  wild-type  mitochondria  with  the  exception  that 
Coa1 is absent. coa1 mitochondria displayed wild type–like 
synthesis of Cox1 but significantly less than coa3 or cox14 
mitochondria (Fig. 5 B). Thus, we concluded that in the absence 
of Coa1, Mss51 is present in the 250-kD complex but not fully 
inactivated and therefore is able to promote translation closely 
resembling the wild-type situation. To demonstrate that the 
250-kD complex in coa1 in fact contained Coa3, Cox14, and 
Mss51, we performed antibody depletion BN-PAGE analyses. 
Incubation with antibodies directed against Coa3 or Cox14 spe-
cifically depleted the 250-kD complex from the extract, whereas 
antibodies directed against Atp5 or Coa1 had no effect (Fig. 7 C). 
In summary, the 250-kD Mss51 complex in coa1 mitochon-
dria  consists  of  Coa3,  Cox14,  and  sequestered  Mss51.  It  is 
likely that this complex is of transient nature in wild type and 
that binding of Coa1 allows subsequent steps of assembly such 
as Shy1 binding. Thus, the 250-kD complex accumulates in the 
absence of Coa1. Despite the presence of Coa3 and Cox14, 
Mss51 is not fully inactivated because COX1 mRNA translation 
occurs in these mitochondria. Thus, we conclude that Coa1 is 
required for full inactivation of Mss51.
Discussion
In mitochondria, translation occurs on membrane-bound ribo-
somes and thus in proximity to respiratory chain complexes. 
This spatial coupling is a prerequisite to link regulation of COX1 
mRNA translation to the assembly state of the Cox1 protein. 
The current model for the regulatory circuit of COX1 mRNA 
translation suggests that Cox14 recruits Mss51 to Cox1 by a yet 
unknown mechanism (Perez-Martinez et al., 2003; Barrientos 
et al., 2004). Thus, physical sequestration is considered to lead 
to inactivation of Mss51 and to block COX1 mRNA translation. 
Coa3 is a novel Cox1-associated factor that negatively regulates 
Cox1 expression. We find that, similar to Cox14, Coa3 is an in-
tegral inner mitochondrial membrane protein exposed to the 
IMS. The topology of Cox14 has been a matter of debate. In agree-
ment with the data presented in this study, initially Cox14 had 
been found to represent a membrane-spanning protein (Glerum   
et al., 1995), but a later study suggested a matrix localization of 
Cox14 (Barrientos et al., 2004).
A minor fraction of Coa3 and Cox14 appears to be associ-
ated with respiratory chain supercomplexes, similar to Shy1 (Mick 
et al., 2007). The function of this pool is still not clear (Stuart, 
2008). It is currently speculated that the supercomplex-associated JCB • VOLUME 191 • NUMBER 1 • 2010   152
dilutions were spotted onto agar plates containing rich medium with glu-
cose or glycerol as carbon source. Plates were incubated at the indicated 
temperatures for up to 72 h.
Pretreatment  of  yeast  cells  with  translation  inhibitors  was  per-
formed as follows. Cells were grown at 30°C on rich medium containing 
3% glycerol to mid–log phase and supplemented with 2 mg/ml chlor-
amphenicol (Osman et al., 2007) or 150 µg/ml cycloheximide in ethanol as 
solvent. Yeast cells were then grown for an additional 3 h, before mito-
chondria were isolated.
Immunofluorescence assay
Yeast cells were grown in rich, nonfermentable medium at 30°C to mid–log 
phase. Mitochondria were stained by incubation of intact cells with 0.5 µg/ml 
MitoTracker orange CMTMRos (Invitrogen) for 30 min at 30°C, followed 
by extensive washing with medium. Cells were fixed by adding formalde-
hyde to a final concentration of 3.7%. Immunofluorescence microscopy 
was  performed  according  to  Girzalsky  et  al.  (1999).  Rabbit  antisera 
against Coa3 were used at dilutions of 1:200. For detection, Alexa Fluor 
488–conjugated goat anti–rabbit IgG (Invitrogen) was used in a dilution of 
1:200. Images were prepared using a microscope (Axioplan 2; Carl Zeiss, 
Inc.) equipped with a Plan-Fluar 100× NA 1.45 oil objective lens (Carl 
Zeiss, Inc.). Images were recorded with a monochrome camera (AxioCam 
MRm camera; Carl Zeiss, Inc.) and processed with Axiovision 4.5 software 
(Carl Zeiss, Inc.).
Protein localization analysis
Analysis was performed essentially as previously described (Mick et al., 
2007). In brief, isolated mitochondria were sonicated using a Branson 
sonifier (model 450; 3 × 30 s; 40% duty cycle) in 10 mM MOPS, pH 7.2, 
and 500 mM NaCl or were extracted with 0.1 M carbonate, pH 10.8, or 
1% Triton X-100 buffer containing 150 mM NaCl. Subsequently, samples 
were subjected to ultracentrifugation at 55,000 rpm, 4°C for 45 min, in a 
TLA-55  rotor  (Beckman  Coulter).  Submitochondrial  localization  was  as-
sessed by proteinase K treatment of intact, swollen (10 mM MOPS, pH 7.2) 
or Triton X-100–lysed mitochondria. After TCA precipitation, samples were 
analyzed by SDS-PAGE and Western blotting.
Determination of enzymatic activities in mitochondria
Malate dehydrogenase activity was determined by following the oxaloacetate-
dependent oxidation of NADH at 340 nm. The assay buffer contained 
100 mM potassium phosphate, pH 7.5, 0.1 mM NADH, and 0.2 mM oxalo-
acetate. Cytochrome oxidase and NADH–cytochrome reductase activ-
ities were assessed spectrophotometrically by measuring absorbance at 
550 nm in buffers containing 40 mM potassium phosphate, pH 7.5, and 
0.02% cytochrome c (Sigma-Aldrich; dithionite reduced for oxidase activ-
ity). Reactions were started by the addition of Triton X-100–lysed mitochon-
dria. For cytochrome reductase activity, nonlysed mitochondria were 
added, and buffer was supplemented with 0.5 mM NADH and 0.1 mM 
KCN (Tzagoloff et al., 1975). Concentrations of reduced/oxidized cyto-




Import of radiolabeled precursor proteins, antibody shift, antibody 
depletion, and coimmunoprecipitation assays
In vitro import of radiolabeled precursor proteins was performed as de-
scribed in Mick et al. (2007). In brief, in vitro translation was performed 
in reticulocyte lysate (Promega) using open reading frames cloned into 
pGEM-4Z under control of the SP6 promotor (Promega). Import and as-
sembly of the radiolabeled preproteins into isolated mitochondria was per-
formed essentially as described previously (Wiedemann et al., 2006). 
Therefore, isolated mitochondria were incubated with radiolabeled precur-
sor proteins at 25°C in import buffer (3% BSA, 250 mM sucrose, 80 mM 
KCl, 5 mM MgCl2, 2 mM KH2PO4, 5 mM methionine, 10 mM MOPS-KOH, 
pH 7.2, 2 mM ATP, and 2 mM NADH) and subjected to a proteinase K 
treatment after the import reaction. For antibody shift or depletion experi-
ments, mitochondria were lysed in BN-PAGE solubilization buffer contain-
ing 1% digitonin. For antibody shift experiments, samples were split in 
50-µg mitochondria aliquots, 2 µg of antibodies against HA (Roche) or Flag 
(Sigma-Aldrich) epitopes was added, and samples were incubated for 30 min 
at 4°C with gentle agitation before separation by BN-PAGE. For depletion 
experiments, samples were split and incubated with antibodies coupled to 
protein A– or protein G–Sepharose (GE Healthcare) for up to 90 min. Un-
bound material was directly used for BN-PAGE analysis. Coimmunoprecip-
itation experiments were performed according to Hutu et al. (2008), with 
the exception that lysis buffers contained 60 mM NaCl.
300-kD complexes. In contrast, when assembly intermediates 
are depleted through chloramphenicol treatment, Mss51 is solely 
present in the translation-effective state (MSS51
TE). We have 
been unable to identify assembly factors or structural subunits 
of the cytochrome oxidase in the MSS51
TE complex by Western 
blotting. Thus, it is tempting to speculate that this complex is an 
oligomeric form of Mss51 or contains subunits that are not yet 
known. At steady-state, all complexes are present in mitochon-
dria, indicating that they are in dynamic equilibrium, which can 
be  observed  by  analyzing  Mss51  complexes  under  different 
growth conditions of yeast (unpublished data). We clearly show 
that Mss51, Shy1, Cox1, Coa1, Cox14, and Coa3 are found in 
the 250- and 300-kD COA complexes, whereas only Mss51 is 
detected in the MSS51
TE complex. This finding partially differs 
from a recent study by Khalimonchuk et al. (2010). However, 
our findings with regard to Cox1 synthesis and complex com-
position in mutants agree well with our characterization of the 
complexes. (a) Shy1 is not required for Mss51, Cox1, Coa1, 
Cox14, and Coa3 complex formation, and shy1 cells display 
reduced Cox1 synthesis compared with wild-type mitochon-
dria. (b) Coa1 is not required for Mss51, Cox1, Cox14, and 
Coa3 complex formation, and coa1 cells display slightly in-
creased Cox1 synthesis compared with wild-type mitochondria. 
(c) Cox14 and Coa3 are required for interaction of Mss51 with 
Cox1, Shy1, and Coa1. In the absence of either Cox14 or Coa3, 
Mss51 is exclusively present in the MSS51
TE complex. In agree-
ment,  coa3  and  cox14  cells  display  drastically  increased 
Cox1 synthesis and a constitutively active Mss51. Obviously, a 
lack of Coa3 or Cox14 shifts the dynamic equilibrium of Mss51 
toward the translation-effective state of Mss51.
Based on our findings, we propose a model in which in-
activation of Mss51 is a sequential process. Initially, Mss51 is re-
cruited to a Cox1, Cox14, Coa3 complex, leading to stabilization 
of Cox1. In this 250-kD form, which accumulates in coa1  
mitochondria, Mss51 is not fully inactivated. Association of Coa1 
is required to shift Mss51 to the latent, translation-inactive state 
and further stabilize Cox1. This step appears to precede Shy1 
association. Thus, we suggest that inactivation of individual 
Mss51 molecules for translation is not necessarily caused by a 
single physical sequestration step. Our data rather suggest that 
inactivation is a multistep process at the inner membrane that 
leads to a sequential inactivation of the Mss51 protein. The equi-
librium between these states is regulated through specific fac-
tors at distinct stages of Cox1 biogenesis, and Coa3 and Cox14 
are the initial factors in the process.
Materials and methods
Yeast strains and mitochondrial isolation
S. cerevisiae strains in this study are derivatives of YPH499 (Sikorski and 
Hieter, 1989), except for Mss51
TAP and Cox14
TAP (BY4741; Thermo Fisher 
Scientific; Mick et al., 2007) and cox1
 and cox2
 (Netter et al., 1982) 
strains. Deletions and tagging of COA3, COX14, and MSS51 were per-
formed by introducing HISMX6 or TRP1 cassettes amplified via PCR with 
site-specific 5 extensions for homologous recombination (Longtine et al., 
1998; Knop et al., 1999). Yeast cells were grown at 30°C in rich medium 
containing 1% yeast extract and 2% peptone or on synthetic medium lack-
ing histidine. As a carbon source, 3% glycerol, 2% galactose, or 2% su-
crose for strains affected in respiration was used. For growth tests, yeast 
cells from liquid cultures were adjusted to an OD600 of 0.3, and serial 10-fold 153 Regulation of mitochondrial COX1 translation • Mick et al.
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